Skip to main content

Table 6 TNF-α gene polymorphisms and the occurrence of interstitial lung fibrosis in SARS patients

From: Roles of TNF-α gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study

SNP site

Interstitial lung fibrosis(%)

Non-interstitial lung fibrosis(%)

OR* (95%C.I.)

P

-1031

    

   Genotype

    

TT

14(70)

12(57.1)

  

CT

6(30)

8(38.1)

0.64(0.17–2.38)

0.51

CC

0

1(4.8)

1.08(0.93–1.27)

0.48

   Allele

    

T

85.00

76.19

  

C

15.00

23.81

  

-863

    

   Genotype

    

CC

17(77.3)

16(72.7)

  

AC

5(22.7)

6(27.3)

0.78(0.20–3.08)

0.73

   Allele

    

C

88.64

38

  

A

11.36

13.64

  

-857

    

   Genotype

    

CC

15(68.8)

17(77.3)

  

CT

7(31.8)

5(22.7)

1.59(0.42–6.07)

0.50

   Allele

    

C

84.09

88.64

  

T

15.91

11.36

  

-572

    

   Genotype

    

AA

21(95.5)

22(100)

  

AC

1(4.5)

0

0.96(0.87–1.05)&

0.50

   Allele

    

A

97.73

100.00

  

C

2.27

0.00

  

-308

    

   Genotype

    

GG

21(95.5)

18(81.8)

  

AG

1(4.5)

4(18.2)

0.21(0.02–2.10)

0.17

   Allele

    

G

97.73

90.9

  

A

2.27

9.1

  

-238

    

   Genotype

    

GG

20(90.9)

18(81.8)

  

AG

2(9.1)

4(18.2)

0.45(0.07–2.76)

0.33

   Allele

    

G

95.45

90.9

  

A

4.55

9.1

  
  1. Note:*:OR was calculated using non-interstitial lung fibrosis as control.
  2. &: Odds ratio replaced with interstitial lung fibrosis group;
  3. ‡: Odds ratio replaced with non-interstitial lung fibrosis group